| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced nanovehicles for cancer management
|
Saenz del Burgo, L.
|
|
2014
|
19 |
10 |
p. 1659-1670
12 p.
|
artikel
|
| 2 |
An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs
|
Kinch, Michael S.
|
|
2014
|
19 |
10 |
p. 1510-1513
4 p.
|
artikel
|
| 3 |
Breaking away from the norm: a new perspective on cancer therapeutics
|
Näsström, Jacques
|
|
2014
|
19 |
10 |
p. 1508-1509
2 p.
|
artikel
|
| 4 |
Cell banking for pharmaceutical research
|
Wrigley, Jonathan D.
|
|
2014
|
19 |
10 |
p. 1518-1529
12 p.
|
artikel
|
| 5 |
Chemical approaches to targeting drug resistance in cancer stem cells
|
Sotiropoulou, Panagiota A.
|
|
2014
|
19 |
10 |
p. 1547-1562
16 p.
|
artikel
|
| 6 |
Contents page 1
|
|
|
2014
|
19 |
10 |
p. i-
1 p.
|
artikel
|
| 7 |
Contents page 2
|
|
|
2014
|
19 |
10 |
p. iii-
1 p.
|
artikel
|
| 8 |
Delivering the promise of SFC: a case study
|
Lindskog, Maria A.
|
|
2014
|
19 |
10 |
p. 1607-1612
6 p.
|
artikel
|
| 9 |
Development of anticancer agents: wizardry with osmium
|
Hanif, Muhammad
|
|
2014
|
19 |
10 |
p. 1640-1648
9 p.
|
artikel
|
| 10 |
Harnessing the anti-inflammatory potential of palmitoylethanolamide
|
Alhouayek, Mireille
|
|
2014
|
19 |
10 |
p. 1632-1639
8 p.
|
artikel
|
| 11 |
Is nanotechnology a boon for oral drug delivery?
|
Agrawal, Udita
|
|
2014
|
19 |
10 |
p. 1530-1546
17 p.
|
artikel
|
| 12 |
mitoNEET as a novel drug target for mitochondrial dysfunction
|
Geldenhuys, Werner J.
|
|
2014
|
19 |
10 |
p. 1601-1606
6 p.
|
artikel
|
| 13 |
Multidrug resistance in cancer or inefficacy of neuroactive agents: innovative strategies to inhibit or circumvent the active efflux transporters selectively
|
Pavan, Barbara
|
|
2014
|
19 |
10 |
p. 1563-1571
9 p.
|
artikel
|
| 14 |
Nutraceuticals in joint health: animal models as instrumental tools
|
Mével, Elsa
|
|
2014
|
19 |
10 |
p. 1649-1658
10 p.
|
artikel
|
| 15 |
Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics
|
ten Brink, M.H.
|
|
2014
|
19 |
10 |
p. 1572-1586
15 p.
|
artikel
|
| 16 |
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
|
Baumann, Andreas
|
|
2014
|
19 |
10 |
p. 1623-1631
9 p.
|
artikel
|
| 17 |
Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer
|
Alama, Angela
|
|
2014
|
19 |
10 |
p. 1671-1676
6 p.
|
artikel
|
| 18 |
Progress in macromolecular crystallography depends on further miniaturization of crystallization experiments
|
Gorrec, Fabrice
|
|
2014
|
19 |
10 |
p. 1505-1507
3 p.
|
artikel
|
| 19 |
Quantifying the probability of clinical trial success from scientific articles
|
Joshi, Vineet
|
|
2014
|
19 |
10 |
p. 1514-1517
4 p.
|
artikel
|
| 20 |
Recent computational advances in the identification of allosteric sites in proteins
|
Lu, Shaoyong
|
|
2014
|
19 |
10 |
p. 1595-1600
6 p.
|
artikel
|
| 21 |
Targeting mitochondrial dysfunction as in aging and glaucoma
|
Osborne, Neville N.
|
|
2014
|
19 |
10 |
p. 1613-1622
10 p.
|
artikel
|
| 22 |
Three dimensional human small intestine models for ADME-Tox studies
|
Yu, Jiajie
|
|
2014
|
19 |
10 |
p. 1587-1594
8 p.
|
artikel
|
Tijdschrift beschrijving